Table 3.
OR (95% CI) | P Trenda | ||||
---|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | ||
Total | |||||
Carbohydrate | |||||
No.of cases/controls (461/495) | 121/118 | 119/120 | 114/125 | 107/132 | |
Crude | 1 | 0.96 (0.67–1.38) | 0.88 (0.62–1.27) | 0.79 (0.55–1.13) | 0.17 |
Model 1b | 1 | 1.05 (0.72–1.53) | 0.91 (0.63–1.34) | 0.75 (0.52–1.08) | 0.10 |
Model 2c | 1 | 0.97 (0.65–1.44) | 0.85 (0.58–1.25) | 0.74 (0.50–1.08) | 0.09 |
Glycemic index | |||||
No.of cases/controls (461/495) | 110/128 | 106/133 | 127/117 | 123/116 | |
Crude | 1 | 0.93 (0.65–1.34) | 1.22 (0.85–1.75) | 1.24 (0.86–1.76) | 0.11 |
Model 1 | 1 | 0.95 (0.65–1.39) | 1.33 (0.91–1.92) | 1.39 (0.96–2.01) | 0.02 |
Model 2 | 1 | 1.04 (0.69–1.54) | 1.34 (0.91–1.97) | 1.41 (0.96–2.07) | 0.04 |
Glycemic load | |||||
No.of cases/controls (452/494) | 116/123 | 114/125 | 115/124 | 116/123 | |
Crude | 1 | 0.96 (0.67–1.38) | 0.98(0.68–1.40) | 1.00 (0.69–1.43) | 0.97 |
Model 1 | 1 | 1.02 (0.70–1.50) | 1.01 (0.69–1.48) | 0.96 (0.67–1.39) | 0.85 |
Model 2 | 1 | 0.95 (0.64–1.42) | 0.91 (0.61–1.34) | 0.94 (0.64–1.37) | 0.71 |
CQI | |||||
No.of cases/controls (452/494) | 126/113 | 117/122 | 113/126 | 105/134 | g |
Crude | 1 | 0.82 (0.58–1.18) | 0.87 (0.61–1.24) | 0.69 (0.48–0.99) | 0.07 |
Model 1 | 1 | 0.81 (0.56–1.16) | 0.81 (0.56–1.15) | 0.61 (0.42–0.89) | 0.01 |
Model 2 | 0.86 (0.59–1.25) | 0.85 (0.59–1.24) | 0.63 (0.43–0.94) | 0.03 | |
Premenopausal | |||||
Carbohydrate | |||||
No.of cases/controls (300/325) | 75/82 | 80/76 | 79/77 | 66/90 | |
Crude | 1 | 1.09 (0.70–1.69) | 1.02 (0.65–1.59) | 0.87 (0.55–1.36) | 0.51 |
Model 1 | 1 | 1.24 (0.77–2.00) | 1.05 (0.66–1.67) | 0.82 (0.52–1.31) | 0.33 |
Model 2 | 1.12 (0.68–1.84) | 0.98 (0.61–1.59) | 0.82 (0.51–1.33) | 0.37 | |
Glycemic index | |||||
No.of cases/controls (300/325) | 66/91 | 74/82 | 77/79 | 83/73 | |
Crude | 1 | 1.21 (0.75–1.98) | 1.47 (0.92–2.34) | 1.63 (1.02–2.60) | 0.02 |
Model 1 | 1 | 1.21 (0.74–1.98) | 1.58 (0.98–2.53) | 1.71 (1.06–2.74) | 0.01 |
Model 2 | 1.35 (0.80–2.26) | 1.62 (0.98–2.67) | 1.85 (1.12–3.07) | 0.01 | |
Glycemic load | |||||
No.of cases/controls (300/325) | 76/81 | 71/85 | 74/82 | 79/77 | |
Crude | 1 | 0.99 (0.62–1.56) | 0.97 (0.62–1.51) | 1.12 (0.72–1.75) | 0.63 |
Model 1 | 1 | 1.11 (0.68–1.81) | 1.04 (0.65–1.65) | 1.13 (0.72–1.77) | 0.67 |
Model 2 | 1.04 (0.62–1.73) | 0.92 (0.57–1.49) | 1.14 (0.71–1.81) | 0.70 | |
CQI | |||||
No.of cases/controls (300/325) | 81/76 | 76/80 | 79/77 | 64/92 | |
Crude | 1 | 0.89 (0.57–1.38) | 0.95 (0.61–1.47) | 0.68 (0.43–1.06) | 0.14 |
Model 1 | 1 | 0.88 (0.56–1.38) | 0.92 (0.59–1.44) | 0.57 (0.36–0.91) | 0.03 |
Model 2 | 1 | 0.84 (0.53–1.35) | 0.94 (0.59–1.49) | 0.55 (0.34–0.90) | 0.04 |
Postmenopausal | |||||
Carbohydrate | |||||
No.of cases/controls (152/160) | 44/34 | 37/41 | 32/46 | 39/39 | |
Crude | 1 | 0.75 (0.40–1.39) | 0.54 (0.28–1.03) | 0.77 (0.42–1.41) | 0.28 |
Model 1 | 1 | 0.69 (0.36–1.31) | 0.51 (0.26–0.98) | 0.79 (0.43–1.45) | 0.32 |
Model 2 | 0.63 (0.32–1.24) | 0.40 (0.19–0.82) | 0.77 (0.41–1.46) | 0.25 | |
Glycemic index | |||||
No.of cases/controls (152/160) | 39/39 | 37/41 | 36/42 | 40/38 | |
Crude | 1 | 0.80 (0.42–1.52) | 0.80 (0.42–1.52) | 1.04 (0.56–1.91) | 0.86 |
Model 1 | 1 | 0.83 (0.43–1.58) | 0.83 (0.43–1.59) | 1.05 (0.57–1.94) | 0.82 |
Model 2 | 1 | 0.89 (0.45–1.75) | 0.86 (0.43–1.71) | 1.01 (0.53–1.91) | 0.97 |
Glycemic load | |||||
No.of cases/controls (152/160) | 41/37 | 40/38 | 37/41 | 34/44 | |
crude | 1 | 0.85 (0.46–1.60) | 0.88 (0.47–1.64) | 0.79 (0.42–1.48) | 0.50 |
Model 1 | 1 | 0.82 (0.43–1.57) | 0.89 (0.46–1.70) | 0.78 (0.41–1.46) | 0.51 |
Model 2 | 1 | 0.74 (0.37–1.47) | 0.78 (0.39–1.54) | 0.73 (0.38–1.40) | 0.40 |
CQI | |||||
No.of cases/controls (152/160) | 43/35 | 40/38 | 31/47 | 38/40 | |
Crude | 1 | 0.95 (0.51–1.77) | 0.52 (0.26–1.02) | 0.82 (0.45–1.51) | 0.28 |
Model 1 | 1 | 0.96 (0.51–1.78) | 0.52 (0.26–1.02) | 0.83 (0.45–1.53) | 0.29 |
Model 2 | 1.03 (0.53–1.99) | 0.59 (0.29–1.20) | 0.87 (0.46–1.66) | 0.41 |
aTrend based on median values of each quartile
bModel 1: Adjusted for age, energy and residential place
cModel 2: further adjusted for oral contraceptive use, parity, marital status, family history of breast cancer, BMI (continuous), and physical activity